Literature DB >> 1173064

Cross-protection among feline caliciviruses.

C Povey, J Ingersoll.   

Abstract

Each of five groups of specific-pathogen-free and conventionally reared cats was infected with a different strain of feline calicivirus. Two of the strains were pathogenic, producing characteristically fever, depression, loss of appetite, buccal ulceration, and occasionally increased ocular and nasal secretion. Two of the other strains were midly pathogenic and associated with fever or buccal ulceration or both; the fifth strain was nonpathogenic. The two pathogenic strains plus three others shown also to be pathogenic were used 3 months after the initial infection to challenge the cats in rearranged groupings. Of the 28 conventional cats challenged six (21.4%) showed at least a febrile response, although none of the 30 specific-pathogen-free cats showed any clinical signs. After challenge, virus was recovered from throat swabs of 37 or the 58 cats (63.8%) including the six which showed symptoms, but the duration of the excretion of virus was significantly less than that seen with the initial infection. The homologous and heterotypic antibody responses correlated well with the clinical protection, or lack of it, seen on challenge. The results provide further evidence for significant cross-relationships between feline caliciviruses.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1173064      PMCID: PMC415151          DOI: 10.1128/iai.11.5.877-885.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  VIROLOGIC STUDIES OF ACUTE RESPIRATORY DISEASE IN YOUNG ADULTS. 3. SOME BIOLOGIC AND SEROLOGIC CHARACTERISTICS OF SEVENTEEN RHINOVIRUS SEROTYPES ISOLATED OCTOBER, 1960, TO JUNE, 1961.

Authors:  D HAMRE; A P CONNELLY; J J PROCKNOW
Journal:  J Lab Clin Med       Date:  1964-09

2.  Further characterization of the local respiratory tract antibody response induced by intranasal instillation of inactivated rhinovirus 13 vaccine.

Authors:  R F Buscho; J C Perkins; H L Knopf; A Z Kapikian; R M Chanock
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

3.  Absence of heterologous antibody responses in human volunteers after rhinovirus vaccination. (Brief report).

Authors:  E J Stott; C Draper; P B Stons; D A Tyrrell
Journal:  Arch Gesamte Virusforsch       Date:  1969

4.  Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness.

Authors:  J C Perkins; D N Tucker; H L Knopf; R P Wenzel; A Z Kapikian; R M Chanock
Journal:  Am J Epidemiol       Date:  1969-12       Impact factor: 4.897

5.  Analysis of the neutralizing activity in nasal wash and serum following intranasal vaccinaion with inactivated type 13 rhinovirus.

Authors:  H L Knopf; J C Perkins; D M Bertran; A Z Kapikian; R M Chanock
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

6.  Serological relationships among feline caliciviruses.

Authors:  R C Povey
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

7.  Evidence for protective effect of an inactivated rhinovirus vaccine administered by the nasal route.

Authors:  J C Perkins; D N Tucker; H L Knope; R P Wenzel; R B Hornick; A Z Kapikian; R M Chanock
Journal:  Am J Epidemiol       Date:  1969-10       Impact factor: 4.897

8.  Feline viruses. I. Characterization of four isolates and their effect on young kittens.

Authors:  P T Bartholomew; J H Gillespie
Journal:  Cornell Vet       Date:  1968-04

9.  Antibody to rhinovirus in human sera. II. Heterotypic responses.

Authors:  W F Fleet; R G Douglas; T R Cate; R B Couch
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

10.  Differences in acute and convalescent-phase antibodies of cats infected with feline picornaviruses.

Authors:  R G Olsen; D E Kahn; E A Hoover; N J Saxe; D S Yohn
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

View more
  13 in total

1.  Antigenic change in feline calicivirus during persistent infection.

Authors:  R P Johnson
Journal:  Can J Vet Res       Date:  1992-10       Impact factor: 1.310

Review 2.  Feline respiratory infections--a clinical review.

Authors:  R C Povey
Journal:  Can Vet J       Date:  1976-04       Impact factor: 1.008

3.  Capsid protein genetic analysis and viral spread to the spinal cord in cats experimentally infected with feline calicivirus (FCV).

Authors:  Y Fujita; Y Sato; K Ohe; S Sakai; M Fukuyama; K Furuhata; S Kishikawa; S Yamamoto; A Kiuchi; M Hara; Y Ishikawa; A Taneno
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

Review 4.  Caliciviruses. Brief review.

Authors:  M J Studdert
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

5.  The preparation of a polyvalent feline calicivirus antiserum.

Authors:  R C Povey
Journal:  Can J Comp Med       Date:  1979-04

6.  The capsid gene of feline calicivirus contains linear B-cell epitopes in both variable and conserved regions.

Authors:  A D Radford; K Willoughby; S Dawson; C McCracken; R M Gaskell
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

7.  Capsid protein gene sequence of feline calicivirus isolates 255 and LLK: further evidence for capsid protein configuration among feline caliciviruses.

Authors:  B S Seal; J D Neill
Journal:  Virus Genes       Date:  1995-01       Impact factor: 2.332

8.  Large-scale spatial and temporal genetic diversity of feline calicivirus.

Authors:  Karen P Coyne; Rob M Christley; Oliver G Pybus; Susan Dawson; Rosalind M Gaskell; Alan D Radford
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

9.  European molecular epidemiology and strain diversity of feline calicivirus.

Authors:  J Hou; F Sánchez-Vizcaíno; D McGahie; C Lesbros; T Almeras; D Howarth; V O'Hara; S Dawson; A D Radford
Journal:  Vet Rec       Date:  2016-01-25       Impact factor: 2.695

Review 10.  Vaccines produced by conventional means to control major infectious diseases of man and animals.

Authors:  J L Bittle; S Muir
Journal:  Adv Vet Sci Comp Med       Date:  1989
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.